Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5900343 | Diabetes Research and Clinical Practice | 2011 | 6 Pages |
Abstract
Individuals with SD T2DM are at high risk of CVD as a result of untreated hyperglycaemia, hypertension and dyslipidaemia. Those prescribed antihypertensive or lipid-lowering therapies frequently still had inadequate control. Identifying vascular risk by screening for latent glucose disease provides therapeutic opportunities for earlier intervention.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
D.R. Webb, L.J. Gray, K. Khunti, S. Campbell, H. Dallosso, M.J. Davies,